Frank Armstrong, M.D., Named Chief Executive Officer of Bioaccelerate Holdings Inc. NEW YORK, April 18 /PRNewswire-FirstCall/ -- Bioaccelerate...
Inncardio, Inc. Announces Agreement With Sigmoid Biotechnologies Ltd. NEW YORK, April 18 /PRNewswire-FirstCall/ -- Inncardio, Inc...
Bioaccelerate Holdings Inc. and Symbollon Pharmaceuticals, Inc. Announce License and Co-Marketing Agreement for IoGen(TM) NEW YORK and...
Expert Panel to Discuss Growing Global Impact and Innovative New Solutions to Emerging Diseases Breakfast Sponsored by Bioaccelerate Holdings Inc...
Innovate Oncology Inc. Announces an Exclusive Agreement With Prostagenics LLC to Develop Capridine-Beta for the Treatment of Prostate Cancer NEW...
Inncardio, Inc. Announces Acquisition of Cengent Therapeutics, Inc. NEW YORK, April 1 /PRNewswire-FirstCall/ -- Inncardio, Inc...
Bioaccelerate Holdings Inc. Announces Equity Investment in Supratek Pharma Inc. NEW YORK, March 24 /PRNewswire-FirstCall/ -- Bioaccelerate...
Inncardio, Inc. Commences Trading on OTCBB Under Ticker 'INDO' NEW YORK, March 4 /PRNewswire-FirstCall/ -- Inncardio, Inc. (OTC:INDO) (BULLETIN...
Softwall Equipment Corp. Inc. Agrees to Acquire Inncardio Inc. SALT LAKE CITY, Feb. 18 /PRNewswire-FirstCall/ -- Softwall Equipment...
Bioaccelerate Holdings Inc. Announces Sponsorship of Milken Institute Global Conference NEW YORK, Feb. 16 /PRNewswire-FirstCall/...
Positive Phase I/II Results from Pancreatic Cancer Study Announced by Bioaccelerate Holdings Inc. and Australian Cancer Technology Data Show...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads